TipRanks
MYUNGMOON Pharm Co., Ltd. (KR:017180)
:017180
South Korea Market
017180
MYUNGMOON Pharm Co., Ltd.
RESEARCH TOOLSreports

MYUNGMOON Pharm Co., Ltd. (017180) Income Statement

― Followers

MYUNGMOON Pharm Co., Ltd. Income Statement

Last quarter (Q2 2026), MYUNGMOON Pharm Co., Ltd.'s total revenue was ₩51.21B, an increase of 5.03% from the same quarter last year. In Q2, MYUNGMOON Pharm Co., Ltd.'s net income was ₩-1.26B. See MYUNGMOON Pharm Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 195.25B₩ 186.44B₩ 169.57B₩ 152.13B₩ 137.76B
Gross Profit
₩ 107.19B₩ 104.97B₩ 95.35B₩ 78.10B₩ 62.34B
Operating Expenses
₩ 100.36B₩ 103.04B₩ 94.39B₩ 71.67B₩ 68.22B
Depreciation and Amortization
₩ 3.29B₩ 4.07B₩ 4.17B₩ 4.24B₩ 4.20B
EBITDA
₩ 10.13B₩ 5.67B₩ 4.52B₩ 10.63B₩ 790.68M
Operating Income
₩ 6.83B₩ 1.93B₩ 963.77M₩ 6.43B₩ -5.88B
Other Income/Expenses
₩ -4.19B₩ -5.67B₩ -5.75B₩ -3.78B₩ -717.32M
Pretax Income
₩ 2.65B₩ -3.74B₩ -4.78B₩ 2.65B₩ -6.60B
Net Income
₩ 1.90B₩ -3.03B₩ -4.52B₩ 7.87B₩ -6.80B
Per Share Metrics
Basic EPS
₩ 56.70₩ -90.62₩ -134.35₩ 232.74₩ -201.27
Diluted EPS
₩ 56.70₩ -90.62₩ -134.35₩ 232.74₩ -201.27
Weighted Average Shares Outstanding
 33.95M 33.48M 33.68M 33.81M 33.81M
Weighted Average Shares Outstanding (Diluted)
 33.95M 33.48M 33.68M 33.81M 33.81M
Currency in KRW

MYUNGMOON Pharm Co., Ltd. Earnings and Revenue History